Hydrochlorothiazide
Brand name: Hydrochlorothiazide
Rank #281 of 500 drugs by total cost
$42.4M
Total Cost
7,879,021
Total Claims
$42.4M
Total Cost
108,281
Prescribers
$5
Cost per Claim
2,272,504
Beneficiaries
19,752,639
30-Day Fills
$392
Avg Cost/Provider
73
Avg Claims/Provider
About Hydrochlorothiazide
Hydrochlorothiazide (sold as Hydrochlorothiazide) was prescribed 7,879,021 times by 108,281 Medicare Part D providers in 2023, costing the program $42.4M. At $5 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 278 | Hydralazine Hcl (Hydralazine Hcl) | $43.2M | 2,256,779 |
| 279 | Leuprolide Acetate (Lupron Depot) | $42.7M | 9,949 |
| 280 | Efgartigimod Alfa-Fcab (Vyvgart) | $42.6M | 1,005 |
| 281 | Hydrochlorothiazide (Hydrochlorothiazide) | $42.4M | 7,879,021 |
| 282 | Tadalafil (Tadalafil) | $42.3M | 91,082 |
| 283 | Topiramate (Topiramate) | $41.9M | 1,141,093 |
| 284 | Latanoprostene Bunod (Vyzulta) | $41.6M | 92,705 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology